Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Der Urologe. Ausg. A
|
March 22, 2017
[When is surgical treatment indicated in metastatic urothelial carcinoma and what is the scientific rationale?]
C Niedworok, H Rübben
Der Urologe. Ausg. A
|
April 22, 2015
[Alternatives to cystectomy]
C Niedworok, C Gratzke
Der Urologe. Ausg. A
|
April 28, 2016
[Organ-sparing treatment of bladder cancer]
C Niedworok, A Shaleva, H Rübben, et al.
Der Urologe. Ausg. A
|
October 16, 2014
[Non-muscle invasive bladder cancer: safety of postoperative EMDA-assisted instillation of mitomycin]
C Rehme, C Niedworok, H Rübben, et al.
Der Urologe. Ausg. A
|
August 22, 2014
[Organ and kidney function preservation in renal cell carcinoma]
M Schenck, R Eder, H Rübben, et al.
Der Urologe. Ausg. A
|
May 10, 2013
[Pedicled prepuce flap plasty: results in patients with hypospadias or urethral sticture]
C Niedworok, K Jürgensen, F Vom Dorp, et al.
Journal of Pediatric Urology
|
November 16, 2020
The value of an additional scrotal suture during orchidopexy
L Hirner, I Rübben, H Lax, et al.
Der Urologe. Ausg. A
|
June 30, 2018
[Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]
M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Der Urologe. Ausg. A
|
September 20, 2011
[How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]
M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Neurourology and Urodynamics
|
September 19, 2014
Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor
C Füllhase, M Hennenberg, P Sandner, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Der Urologe. Ausg. A
|
March 22, 2017
[When is surgical treatment indicated in metastatic urothelial carcinoma and what is the scientific rationale?]
C Niedworok, H Rübben
Der Urologe. Ausg. A
|
April 22, 2015
[Alternatives to cystectomy]
C Niedworok, C Gratzke
Der Urologe. Ausg. A
|
April 28, 2016
[Organ-sparing treatment of bladder cancer]
C Niedworok, A Shaleva, H Rübben, et al.
Der Urologe. Ausg. A
|
October 16, 2014
[Non-muscle invasive bladder cancer: safety of postoperative EMDA-assisted instillation of mitomycin]
C Rehme, C Niedworok, H Rübben, et al.
Der Urologe. Ausg. A
|
August 22, 2014
[Organ and kidney function preservation in renal cell carcinoma]
M Schenck, R Eder, H Rübben, et al.
Der Urologe. Ausg. A
|
May 10, 2013
[Pedicled prepuce flap plasty: results in patients with hypospadias or urethral sticture]
C Niedworok, K Jürgensen, F Vom Dorp, et al.
Journal of Pediatric Urology
|
November 16, 2020
The value of an additional scrotal suture during orchidopexy
L Hirner, I Rübben, H Lax, et al.
Der Urologe. Ausg. A
|
June 30, 2018
[Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]
M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Der Urologe. Ausg. A
|
September 20, 2011
[How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]
M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Neurourology and Urodynamics
|
September 19, 2014
Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor
C Füllhase, M Hennenberg, P Sandner, et al.
Page
of 2